Open an account

Petmed Express

PETS · NASDAQ

$1.20+$0.05 (+4.35%)TodayMarket closed ·
Prev close $1.15

About PETS

PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Employees
173
Headquarters
Delray Beach, Florida
Listed
Apr 6, 2000
Sector
Consumer Discretionary
Industry
Specialty Retail
Website
1800petmeds.com

PETS key statistics

Market cap
26.01M
Price-earnings ratio
0.00
Dividend yield
0.10%
Average volume
131.47K
Volume
131.80K
Open price
$1.15
High today
$1.21
Low today
$1.15
52 Week high
$4.10
52 Week low
$1.15

Petmed Express (PETS) at a glance

As of Oct 20, 2026, Petmed Express (PETS) shares are priced at $1.20, giving the company a market cap of 26.01M, a price-to-earnings ratio of 0.00 and a dividend yield of 0.10%.

Today the stock has traded between $1.15 and $1.21. The current price is 4.3% above the day's low and 0.8% below its high.

Volume so far is 131.80K shares, in line with the average of 131.47K shares a day.

Over the past year Petmed Express has ranged from $1.15 to $4.10, and now sits 2% of the way up that range.

Petmed Express met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.28 per share against an estimate of $0.1224.

The average analyst price target is $1.43, 19.0% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold0.0%
  • Sell100.0%
Price target · 3 analystsAvg $1.43
Low
$1.41
Now
$1.20
High
$1.47

PETS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 296.1% on average.

  1. Q4 FY24: reported -$0.25 per share against an estimate of -$0.0714
  2. Q1 FY25: reported $0.18 per share against an estimate of -$0.0918
  3. Q2 FY25: reported $0.11 per share against an estimate of -$0.0561
  4. Q3 FY25: reported -$0.03 per share against an estimate of -$0.0051
  5. Q4 FY25: reported -$0.5642 per share against an estimate of -$0.0459
  6. Q1 FY26: reported -$0.19 per share against an estimate of -$0.1836
  7. Q1 FY27: reported -$0.28 per share against an estimate of $0.1224
  8. Q2 FY26: reported -$0.28 per share against an estimate of $0.1224

PETS news

  • Press releaseGlobe Newswire

    PetMeds® Announces First Quarter Financial Results

  • Kaustubh Bagalkote

    Activist Investor Slams PetMed Board For 'Stunning Destruction' Of Shareholder Value

  • 12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

  • Press releaseGlobe Newswire

    PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

  • 12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

  • 12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

  • 12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

Similar companies

Companies in the same industry as Petmed Express

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.